✦ LIBER ✦

SUPPLEMENTATION WITH THE PROBIOTIC VSL#3 IN PATIENTS WITH MILD-TO-MODERATE ACTIVE ULCERATIVE COLITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY

✍ Scribed by A. Tursi; A. Papa; G. Brandimarte; A. Giglio; W. Elisei; G.M. Giorgetti; G. Forti; S. Morini; C. Hassan; M.A. Pistoia; M.E. Modeo; S. Rodinò; E. Di Giulio; F. Luzza; S. Di Rosa; V. Annese; S. Danese; A. Gasbarrini

Book ID: 119633182
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 123 KB
Volume: 41
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(09)60150-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

388 Supplementation with the Probiotic V

388 Supplementation with the Probiotic VSL#3 in Patients with Mild-to-Moderate Active Ulcerative Colitis: A Double-Blind, Randomized, Placebo-Controlled Study

✍ Antonio Tursi; Giovanni Brandimarte; Alfredo Papa; Andrea Giglio; Walter Elisei; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 89 KB

701 A Randomized, Double-Blind, Placebo-

701 A Randomized, Double-Blind, Placebo-Controlled Trial of a Probiotic Preparation, Vsl#3, for the Treatment of Mild to Moderate Active Ulcerative Colitis

✍ Govind K. Makharia; Ajit Sood; Vandana Midha; Vineet Ahuja; Dinesh K. Singal; Re 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Probiotic preparation VSL#3 induces remi

Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: A pilot study

✍ Hien Q. Huynh; Jennifer deBruyn; Leluo Guan; Hugo Diaz; Meiju Li; Safwat Girgis; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

## Background: Ulcerative colitis (uc) is a form of inflammatory bowel disease (ibd) that has periods of exacerbated symptoms and periods that are symptom-free. the treatment of active uc with probiotic bacteria could possibly induce remission. we evaluated the clinical efficacy and safety profile

A Randomized, Double-blind, Placebo-Cont

A Randomized, Double-blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease

📂 Article 📅 2013 🏛 American Medical Association 🌐 English ⚖ 231 KB

MMX Multi Matrix System® mesalazine for

MMX Multi Matrix System® mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials

✍ W. J. SANDBORN; M. A. KAMM; G. R. LICHTENSTEIN; A. LYNE; T. BUTLER; R. E. JOSEPH 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 566 KB

Effects Of MN-001 In Patients With Mild-

Effects Of MN-001 In Patients With Mild-to-moderate Asthma In A Randomized, Double-blind And Placebo-controlled Phase II Study

✍ Busse, W.W.; Nelson, H.S.; Korenblat, P.E.; Noonan, M.J.; Locke, K.W.; Munsey, M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB